Rachel Geman

Working for Employees, Whistleblowers, and Consumers

A partner in our New York office, Rachel Geman presently serves on the Plaintiffs’ Steering Committee of the Valsartan NDMA Products Liability Litigation (contaminated drugs); is Co-Lead Counsel for Relator in litigation involving kickbacks in the sale of AbbVie’s drug HUMIRA; represents large municipalities in civil rights litigation; and has filed under seal matters on behalf of whistleblower clients in a number of industries. Rachel is on the team representing a certified class of women in employment discrimination litigation against Goldman Sachs.

Examples of Rachel’s past successes include:

Employment law: Rachel represented employee benefit plans in recovering $65 million from AXA Rosenberg to settle ERISA and other claims, and represented a class of female financial advisors who secured $39 million plus injunctive relief from Bank of America/Merrill Lynch to settle discrimination claims.

Consumer protection: Rachel served as co-lead class counsel or counsel for the class in consumer financial litigation over “payment protection” products, resulting in more than $50 million in settlements. Earlier in her career, Rachel worked on multiple predatory lending and servicing cases on behalf of borrowers, including cases against Ameriquest, Ocwen, Fairbanks, and other lenders.

False Claims Act: Rachel helped recoup $78.5 million from the University of Phoenix for the Government, one of the largest settlements involving fraud on the Department of Education, and she has been lead counsel on recent settlements of off-label marketing and kickback cases.

To stay fresh on different perspectives and evolving issues in complex fraud, Rachel maintains a credential as a Certified Fraud Examiner. She also chairs NELA-NY’s amicus committee, and is active in her children’s local school.